Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy? - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutic Année : 2015
Fichier non déposé

Dates et versions

hal-02415080 , version 1 (16-12-2019)

Identifiants

  • HAL Id : hal-02415080 , version 1

Citer

François Guérard, Jacques Barbet, Ferid Haddad, Michel Cherel, Francoise Kraeber-Bodere, et al.. Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutic, 2015. ⟨hal-02415080⟩
65 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More